|
House Bill 3703 |
House Author: Klick et al. |
|
Effective: 6-14-19 |
Senate Sponsor: Campbell et al. |
House Bill 3703 amends the Medical Practice Act, Occupations Code, to expand the medical conditions for which a patient may be prescribed low‑THC cannabis for compassionate use to include all forms of epilepsy as well as the following: a seizure disorder, multiple sclerosis, spasticity, amyotrophic lateral sclerosis, autism, terminal cancer, or an incurable neurodegenerative disease. The bill revises what constitutes low‑THC for purposes of such a prescription by removing the condition that cannabis containing not more than 0.5 percent by weight of THC also contain not less than 10 percent by weight of cannabidiol. The bill removes the requirement that a second licensed physician qualified to prescribe low‑THC cannabis concur with a determination that the risk of the medical use of low‑THC cannabis by the patient is reasonable in light of the potential benefit for the patient and that the concurrence be recorded in the patient's medical record.